Oncology Conferences | Cancer Conferences | Oncologist Meetings | Haematology Conferences |Cancer MeetingsI International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

Theme: An Eye towards â€œHAEMATOLOGY & MEDICAL ONCOLOGYâ€

Medical Oncology-2018

Medical oncology 2018

Medical Oncology-2018

Conference Series llc LTD invites all the participants from all over the world to attend International Conference on "Haematology and Oncology” during May28- 30, 2018 in Osaka, Japan. The conference will be organized around the theme “An Eye towards “Haematology and Oncology”

Why to attend?

With members from around the world focused on learning about Hematology and Blood Disorders; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Haematology & in oncology, treatment and surgery involved are hallmarks of this conference.

Haematology and Oncology 2018 welcomes immunologists, pathologists, haematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Target Audience:

Business Entrepreneurs Public
Health Professionals
Drug Manufacturing Companies
Radiation Therapist
Oncology Societies
Clinical Researchers
Leading world Doctors
Surgical and Medical Hematologist
Young Researchers
Students & Delegates

Conference highlights

Haematology
Haematologic-Oncology
Blood Disorders and Blood oncology
Leukemia Immunology
Haemato Immunology &Stem Cell Research
Haematological malignancies
Biomarkers
Advances in Bone Marrow Transplantation and surgery
Oncology
Cancer Epidemiology
Gynecologic oncology

Summary

Hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. A blood cell disorder is a condition in which there’s a problem with your red blood cells, white blood cells, or the smaller, circulating cells called platelets, which are critical for clot formation. All three cell types form in the bone marrow, which is the soft tissue inside your bones.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Hematology and Oncology 2018, where you will be sure to have a meaningful experience with scholars from around the world.

Importance & scope

Hematology & oncology Conference- Osaka, japan is the best platform for the experts, doctors, researchers, students and business delegates with its well organized scientific program covering every minute detail about Hematology and blood diseases, from the basic causes behind blood diseases to the latest trends in diagnostic and treatment of blood diseases. This international event is an effort to find a weapon against chronic disorders like blood cancer, Sickle cell anaemia, haemophilia, lymphoma and myeloma and to discuss the role of Immunoglobulin in blood, antibody and antigen reactions, the red blood cell and the immunological properties of blood which gives a better insight about the associated causes and disease portfolio.

Conference Series llc LTD welcomes all the haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Blood Disorders 2018. Advanced Diagnostic and therapeutic equipment along with the novel drugs for the blood diseases are an integral part of the Hematology research, hence it will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why Osaka, Japan?

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

Cancer Universities in Japan

National Cancer Centre Hospital
Aichi Cancer Centre
Kyoto Prefectural University of Medicine
Tohoku University
Kyoto University
Chiba University
Osaka University

Universities Worldwide

University of Oxford
University of Cambridge
UCL London's Global University
Stanford University
Western University
University of Nottingham
University of Bologna
University of Athens
University of Chicago
University of Washington
University of Rochester
The University of Melbourne
University of Glasgow
Fudan University
Stanford University
University of Minnesota
University of Albert
University of Nebraska
University of Iowa Carver
University of Pennsylvania
South-western University
University of Pittsburgh
University of Helsinki
University of Penn Medicine

Universities in Asia

Osaka University
Tsinghua University
Fudan University
Taipei Medical University
KAIST - Korea Advanced Institute of Science and Technology
Yonsei University
Shanghai Jiao Tong University
Nanyang Technological University (NTU)
Chulalongkorn Universit
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan Universit
Indian Institute of Science
University Kebangsaan Malaysia (UKM)
University Saints Malaysia (USM)
Beijing University of Chinese Medicine
National Tsing Hua University

Ratio of universities worldwide (fig 1)

Associations in Japan

The Japanese Breast Cancer Society
The Japanese Cancer Association
Japan Society of Clinical Oncology
Japanese Gastric Cancer Association
The Japanese Society of Hematology
The Japan Lung Cancer Society
Japanese Society of Medical Oncology (JSMO)
The Japanese Society of Paediatric Hematology/Oncology
Japan Primary Care Association

Associations Worldwide

Life South Community Blood Centre
World congress of the International society of Hematology
International society of Hematology
World federation of Haemophilia
European Hematology Associations
Malaysian society of Hematology
Armenian associations of Hematology & Oncology
Japanese society of Hematology
Japan Primary Care Association

Association in Asia Pacific

The Asia-Pacific Urogynecology Association
The Asia-Pacific Cancer Society Training
Asian Cancer Foundation India
The Max Foundation
Childhood Cancer International Netherlands
The Asia Pacific Prostate Society

Ratio of Associations in worldwide (fig 2)

Pharmaceutics company in Japan

Takeda
Otsuka
Meiji
Daiichi Sankyo
Astellas
Teijin
Chugai
Mitsubishi Tanabe
Kyowa Hakko Kirin
Taisho
Shionogi
Ono
Hisamitsu
Santel
Kyorin
Nichi-Iko
Mochida
Kaken
Sawai
Kissei
Towa
Zeria
Torii
takedaDaito

Cancer hospitals in Japan

St Luke's International Hospital
National Cancer Centre Hospital, Tokyo ,Japan
Japan Red Cross Medical Centre
Shizuoka Cancer Centre
Chiba university hospital

Cancer hospitals worldwide

Leiden University Medical Centre
Royal Cancer Hospital
King’s College Hospital
Clatter bridge Centre for Oncology
Northampton General Hospital
Cambridge University Hospitals
University Hospital Southampton
Central Manchester University Hospitals

Track 1: Hematology

Erythrocytes are also called as red platelets which convey oxygen to the body and gather carbon dioxide from the body by the use of hemoglobin and its life expectancy of 120 days. At the edge the leucocytes helps in ensuring the healthy cells in light of the fact that the W.B.C (leucocytes) go about as the defending cells in protecting the immune system from the outside cells. Formation of blood cellular componrents are called as Hematopoiesis and all the cellular blood segments are gotten from hematopoiesis stem cells in a healthy individual almost 1011–1012 fresh blood cells are produced these assistance in steady peripheral circulation. In the event that there is an increments of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 2: Hematologic-oncology

Hematologic Oncology is the branch of medicine study about the diagnosis ,prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Hematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumor. There are different disorders that people are influenced by hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.

Track 3: Blood Disorders and Blood oncology

Iron deficiency is the most well-known sort of blood issue we treat. Patients with anaemia have an insufficiency of oxygen-rich red platelets or their red platelets don't work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Anaemia can be constant, or a brief condition caused by other medical problems, including growth treatment, hepatitis C, and HIV/AIDS. Anemia every now and again stays undiscovered in light of the fact that it is a fundamental state of other medical problems, including growth, cardiovascular malady, diabetes, HIV/AIDS, fiery entrail sickness, unending kidney infection, and rheumatoid joint pain. Hemophilia is a rare typicall inherited blood disorder, commonly acquired blood issue in which the blood does not appropriately clump and causeintemprate dying, which can make harm organs, joints, and tissues. Patient may experience the ill effects of the site of damage or from inward dying. Coagulating Disorders Hematologists likewise treat conditions identified with the proteins that trigger draining and thickening, including thrombosis (thickening) and hemostasis (dying). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Track 4: Leukemia immunology

Cancer immunology is a branch of immunology that studies interaction between the immune system and cancer cells (likewise called tumors or malignancies). It is a developing field of research that plans to find inovative malignancy immunotherapies to treat and retard movement of diseaes. The immune system reaction, including the acknowledgment of disease particular antigens, is specifically compelling in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumor marker-based diagnostic tests.

Track 5: Hemato- Immunology & Stem Cell Research

Blood group are of ABO sort and however at introduce the Rh blood gathering of 50 very much characterized antigens in which 5 are more vital they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in anticipation of erythroblast fetalis lacking of Rh antigen it characterized as negative and existences of Rh antigen in blood prompts positive these prompts rh inconsistency. The prevention treatment of illnesses identified with the blood is called as the Hematology. The haematologists conduct a work at cancer to. The disorder of immune system leading to the hypersensitivity is called as Clinical Immunology and the abnormal development of a disease are known as Inflammation and the emerge of an abnormal immune reaction to the body or an immune suppression are known as Auto immune disorder. The undifferentiated cell treatment is utilized to treat or keep an illness or a condition for the mostly Bone marrow undifferentiated cell treatment is seen and as of late umbilical cord treatment Stem cell transplantation methodologies remains an unsafe system with many possible confusions; it is saved for patients with life-threatening sicknesses.

Track 6: Cancer and Alternative Medicine

Ayurvedic drug is an old Indian system of medication which started around 5,000 years prior. It is not only one treatment. It is a method for diagnosing disease and utilizing an extensive variety of medications and strategies. Home grown medication utilizes plants, or blends of plant mixture, to treat disease and promote health. It intends to restore your body's capacity to secure, manage and heal itself. It is an entire body approach, so look at your physical, mental and emotional well-being. It is now and again called phytomedicine, phytotherapy or natural pharmaceutical. Naturopathic specialists (NDs) trust that cancer emerges from an imbalance that causes a systemic breakdown inside the body. Homeopathy depends on the hypothesis of treating like with like. So to treat a sickness a homeopathic specialist (homeopath) utilizes minor dose of a substance that in large dosages would actually cause the symptom of the illness.

Track 7: Haematological malignancies

Hematologic malignancies are types of cancer that starts in the cells of blood-shaping tissue, for example, the bone marrow, or in the cells of the immune system. Cases of hematologic disease are intense and endless Leukemia, lymphomas, and numerous myeloma and myelodysplastic disorders. Myeloproliferative neoplasms, or MPNs, are hematologic growths that arise from dangerous hematopoietic myeloid progenitor cells in the bone marrow, for example, the precursor cells of red cells, platelets and granulocytes .Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera and myelofibrosis . This logical session will concentrate on a wide range of normal or uncommon blood tumours, for example, intense promyelocytic Leukemia (APL) and interminable myelomonocytic Leukemia bristly cell Leukemia (HCL), expansive granular lymphocytic Leukemia (LGL), white blood cell intense lymphoblastic Leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative disease. The estimate of how the disease will go for a patient is called prognosis. There are many factors influence prognosis that include: the kind of cancer and where it is in the body, the phase of the cancer, the cancer grade. Grad gives signs about how rapidly the disease is probably going to develop and spread certain traits of the tumour cells, the age and how healthy body was before cancer and how fruitful is the treatment.

Track 8: Biomarkers

Protein Biomarkers can be used as biomarkers for early recognition of cancer particularly used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will experience an underlying CT scan to decide if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-respectable stage III and IV disease and a biopsy will be attempted to confirm pancreatic tumour by H&E pathological assay. The presence of cancerous cells by means of pathology is very challenging because of high quantities of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will just initiate on definitive diagnosis of pancreatic cancer. These will see particularly stains neoplastic pancreatic cells would empower the pathologist to confidently diagnose pancreatic cancer and in this way offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been recognized as a highly sensitive (98%) and particular (95%) IHC marker for pancreatic cancer and CRT is looking for a partner to build up an IHC based test to distinguish BI-010 in fine needle suction biopsies from biopsy tests.

Track 9: Advances in Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also called as haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow cells. Bone marrow is an elastic tissue found in the empty focuses of a few bones. It contains specialist stem cell, which create the body's cell. A biopsy is a specimen of tissue taken from the body in order to examine it more intently. A doctor should prescribe a biopsy when an initial test suggests that a region of tissue in the body isn't normal. Doctors may call that region of abnormal tissue an injury, a tumour, or a mass.Topics of exchange in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations. An expanding number of diseases may be treated effectively by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell arrangement or product is replaced, it has now turned out to be standard treatment for some types of Leukemia where the transplant gives the protection after deadly marrow removal. As of recent, disease, for example, thalassemia and other acquired metabolic illnesses have also been treated with by BMT. In the past the issues of BMT were for the most part worried about graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was generally fatal. Since the advancement of methods for T cell removal the occurrence of GVHD has greatly diminished. White blood cell removal has likewise permitted HLA haploidentical mismatched graft to be performed effectively for immunodeficiency, but still there is a high graft rejection rate in Leukemia.

Track 10 : Oncology

Oncology is the study of tumour. An oncologist is a master who treats cancer. More often than not, an oncologist manages care and treatment once he or she is determined to have cancer. A therapeutic oncologist treats cancer using chemotherapy or diverse medications, for instance, targeted therapy. A surgical oncologist removes the tumour and nearby tissue in the midst of an operation. A radiation oncologist treats cancer using radiation therapy. Oncologists may segment on the introduction of the kind of treatment given to treat the cancer. Molecular oncology is the study of science of disease and tumour cell at its molecular cell. Surgical oncology is the branch of oncology which deals with the surgery associated with oncology. Gynaecologic oncology is one which focuses on different developments of the female reproductive system.

Track 11: Cancer Epidemiology

The study of disease transmission of tumour is the investigation of the components affecting development, as a way to deal with finds possible examples and causes. Epidemiology is the investigation of the circulation and determinants of wellbeing related states or events in demonstrated masses, and the use of this audit to control of well-being issues. The most basic risk variable is age. Other hazard components fuse tobacco smoking, alcohol drinking and physical dormancy.

Track 12: Gynaecologic oncology

Gynaecologic is a specific field of medication that spotlights on developments of the female conceptive structure, including ovarian cancer, uterine tumour, vaginal disease, cervical cancer, and vulvar disease. As specialists, they have wide get ready in the conclusion and treatment of these tumours. A gynaecologic oncologist is a specialist who represents impressive expert in diagnosing and treating disease that are arranged on a woman's conceptive organs.

Track 13 : Oncology nursing

An oncology nurse is a selected nurture who takes care of and shows patients who have tumour. Oncology specialists work in a multi-disciplinary gathering, in a combination of settings, from the inpatient ward, where it counts marrow transplant unit, through to the group. They may work with a variety of patients, from children to the elderly, from outpatients through to palliative care.

Track 14 :Haematology in Aquatic Species

The study of the inherent flow properties of the blood itself (hemorheology) is rarely discussed when addressing diving. However, hemorheology is important to the study of marine mammals because of the critical nature of the oxygen stores that are carried in the blood during diving periods. This review focuses on the essential elements of hemorheology, how they are defined and on fundamental rheological applications to marine mammals. While the comparative rationale used throughout the review is much broader than the particular problems associated with diving, the basic concepts focus on how changes in the flow properties of whole blood would be critical to oxygen delivery during diving.

Track 15 :Radiology and Radiation Therapy

Radiation treatment or radiotherapy, commonly abbreviated RT, RTx. This is a treatment utilizing ionizing radiation, by and large as a part of cancer treatment to control or kill harmful cells and typically conveyed by a linear accelerator. Radiation treatment might be curative in various types of cancer if they are confined to one area of the body. It might likewise be utilized as a major aspect of adjuvant therapy, to prevent tumor repetition after surgery to remove a primary harmful tumor (for example, beginning periods of breast cancer). The subspecialty of oncology worried about radiotherapy is called radiation oncology.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 28-29, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Testimonials

This was really a remarkable conference from oncologists 2016 where new advances and some new methods and techniques looking in cancer were discussed in the meeting. I find this conference always very interesting, these people comes from all over the world, The presentation are usually very good, I think itâ€™s very useful and worth full to attend conference series conferences.
Diana Anderson, University of Bradford, UK

Thanks for arranging such amazing meeting.I am lucky to be one of the speeaker in the meeting.
Wen-Lung Ma, China Medical University Hospital, Taiwan

The conference was very interactive and quite interesting, as I have come from all the way from north Carolina to attend this conference, I have enjoyed every bit of learning new sciences in the field of oncology which is my research field. I am very grateful to the organiser especially omics for inviting me and giving me a chance to present my research work here at oncologists 2016, Cologne, Germany.
HirendraNath Banerjee,Elizabeth City State University, USA

World Haematology and Medical Oncology Conference May 28-29, 2018 Osaka, Japan

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links